Animals
C57BL/6 wild-type animals were obtained from SLAC Laboratory Animal (Shanghai). B6D2F1 wild-type males were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. Genetically modified animals, including Calb1-Cre (Calb1tm2.1(cre)Hze/J, #028532), Pomc-Cre (Tg(Pomc1-cre)16Lowl/J, #005965), Agrp-Cre (Agrptm1(cre)Lowl/J, #012899), and Adcyap1-Cre (Adcyap1tm1.1(cre)Hze/ZakJ, #030155), were purchased from the Jackson Laboratory. These animals were housed at the Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) animal facility. All Cre lines were backcrossed onto the C57BL/6 background for more than two generations unless stated otherwise. To produce Pomc-Cre animals with a hybrid background, Pomc-Cre females on the C57BL/6 background were mated with DBA mice, purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. Only heterozygous animals for Cre alleles were used in the study. Only adult animals (8-24 weeks for males, and 6-24 weeks for females) were used. Animals were maintained on a reversed 12 h:12 h light/dark cycle with food and water provided ad libitum. Littermates were randomly assigned to the experimental or control group. All experimental protocols were approved by the Animal Care and Use Committee of CEBSIT, Chinese Academy of Sciences, Shanghai, China (IACUC No. NA-016-2016).
Virus
The following viruses were used in this study: AAV-hSyn-DIO-TVA-mCherry-2A-oG (serotype 2/9, titer 4.8×1013 vg/mL), AAV-hSyn-DIO-EGFP-cry2-Mon-Stim1 (serotype 2/8, titer 1.08×1013 vg/mL) were purchased from CEBSIT gene editing core facility. AAV-EF1a-DIO-RVG (serotype 2/9, titer 2.0 ×1012 vg/mL), AAV-EF1a-DIO-EGFP-2A-TVA (serotype 2/9, titer 2.0 ×1012 vg/mL), RV-EnVA-deltaG-dsRed (2x 108 infectious units / ml) were purchased from BrainVTA, Wuhan. AAV-hSyn-DIO-GCamp6s (serotype 2/8, titer 8.0×1012 vg/mL), AAV-hSyn-DIO-EYFP (serotype 2/8, titer 5×1012 vg/mL), AAV-hSyn-DIO-mCherry (serotype 2/5, titer 3.5×1012 vg/mL), AAV-hSyn-FAS-GCamp6s (serotype 2/9, titer 7.0×1012 vg/mL), AAV-hSyn-FAS-EYFP (serotype 2/9, titer 4.0×1012 vg/mL), AAV-hSyn-DIO-ChR2-mCherry (serotype 2/9, titer 6.0×1012 vg/mL), AAV-hSyn-FAS-ChR2-mCherry (serotype 2/9, titer 6.0×1012 vg/mL), AAV-hSyn-DIO-NpHR3.0-mCherry (serotype 2/9, titer 3 ×1012 vg/mL), and AAV-CAG-DIO-taCaspase3-TEVp (serotype 2/5, titer 8.5 ×1012 vg/mL) were purchased from Taitool Bioscience, Co., Shanghai. Rabies-SADδG-GFP-EnVA virus was generated as described before55,56. Briefly, rabies- SADδG -GFP viruses (RVdG-GFP) were amplified from local viral stocks in B7GG cells (kindly provided by Dr. Ed Callaway, Salk Institute). EnVA pseudotyped rabies was generated in BHK-EnVA cells. The virus was concentrated by two rounds of centrifugation, suspended in Hank’s Balanced Salt Solution (GIBCO), and titered in HEK293-TVA cells (kindly provided by Dr. J. A. T. Young, Salk Institute) with serial dilutions of the virus. The titers of the RVdG-GFP-EnVA were in the range of 107 – 108 infectious units / mL. The virus was stored at -80℃ until use.
Stereotactic surgery
All surgeries were performed as previously described8. Animals were anesthetized under isoflurane (0.8% - 5%) and mounted to a stereotaxic frame (David Kopf Instrument, Model 1900). Surgeries were performed with steady isoflurane (1-2%) in mixed air (95% O2, 5% CO2). For viral injection, the skull was exposed with a small incision, and holes were drilled for virus delivery with glass pipettes (15 - 25mm in diameter at the tip). The following coordinates, according to the standard mouse brain atlas (Paxinos and Franklin Mouse Brain Atlas, 2nd edition), were used to target the arcuate nucleus, AP: - 1.85 mm, ML: ± 0.25 mm, DV: - 5.85 mm; POA, AP: + 0.10 mm, ML: ± 0.40 mm, DV: - 5.15 mm. We injected 200 - 400 nL virus into each site at 80-100 nL / min with a homemade injector (adapted from MO-10 Narishige, Japan). The pipette was left in place for about 10 mins after the injection for virus diffusion.
For fiber photometry recording experiments, the virus was unilaterally injected, and an optic fiber (diameter, 200 mm; N.A., 0.37; AniLab Software and Instruments Co., Ltd) was implanted 50 mm above the coordinates of the virus injection site. For optogenetic activation, the virus was unilaterally injected, and an optic fiber (diameter, 200 μm; N.A., 0.37; AniLab Software and Instruments Co., Ltd) was implanted 200 μm (ARC), or 400 μm (POA) above the coordinates of the virus injection site. For optogenetic inhibition, the virus was bilaterally injected, and dual optic fibers (DFC_200/245–0.37_6.0mm_DF0.9_FLT; Doric Lense) were implanted 400 μm (POA) above the coordinates of the virus injection site. The implanted optic fibers were secured onto the skull with adhesive MetaBond (C&B MetaBond).
For pharmacological experiments, a cannula was implanted for drug infusion in the lateral ventricle. A single guide cannula (#62004, RWD Life Science) was unilaterally implanted to target either the left or right lateral ventricle with the coordinate AP: - 0.30 mm, ML: ± 1.00 mm, DV: - 1.50 mm. The guide cannula was inserted with a dummy cannula (#62108, #62168, RWD Life Science) to prevent clogging during the recovery period and secured with a dust cap.
For neural tracing experiments (Fig. 3a-3b, Extended Data Fig. 8), the virus was bilaterally injected. For pseudorabies tracing experiments, approximately 150 nL of a 1:1 mixture of helper viruses (AAV-EF1a-DIO-RVG and AAV-EF1a-DIO-EGFP-2A-TVA) or 150 nL of AAV-hSyn-DIO-TVA-mCherry-2A-oG alone was unilaterally injected into the ARC of Pomc-Cre mice. Three weeks later, ~100–150 nL of RV-EnVA-deltaG-DsRed or Rabies-SADδG-GFP-EnVA was injected into the same location.
Female receptivity induction
C57BL/6J wild-type female mice were surgically ovariectomized as adults (6-8 weeks age) and hormonally primed to induce receptivity. Hormones were suspended in sterile sunflower seed oil (Sigma-Aldrich, S5007). We injected 10 μg (in 50 μL oil) and 5 μg (in 50 μL oil) of 17b- estradiol benzoate (Sigma-Aldrich, E8875) 48 h and 24 h preceding the mating test. On the test day, females were injected with 50 μg of progesterone (Sigma-Aldrich, P0130; in 50 μL oil) 4 – 6 h prior to the mating test. All the females were hormone primed and trained at least twice with males to obtain sexual experience before being used in experiments. Females were given at least a seven-day interval between two mating test trials.
Male mating behavior test
All males, except those used for optogenetic activation experiments in Extended Data Fig. 5, had prior sexual experience with females. This experience consisted of two sessions of either overnight co-housing with a female or training during a mating behavior test where the males achieved ejaculation. Details regarding the males' sexual experience are provided in Extended Data Table 1. Males were single-housed for 5–7 days before the behavior test. The tests began at least one hour after the onset of the dark cycle and were recorded using an infrared camera at a frame rate of 25 Hz. Mice were first transferred to the test room in their home cages and allowed to acclimate for at least 10 minutes. For each mating trial, a hormone-primed female was introduced into the male’s home cage, where they interacted freely for 30-60 minutes, unless otherwise specified. Afterward, the female was removed. Mating tests were conducted 1– 4 times for each male, with a minimum interval of three days between trials, except for those conducted before the CPP experiments.
Videos were manually annotated frame-by-frame using a custom MATLAB program, as previously described8. Specific male-initiated actions, including genital sniff, mount, intromission, and ejaculation, were defined and annotated by experimenters blinded to the experimental group information. “Genital sniff” was defined as an anogenital investigation when the male initiated nose-to-anogenital contact. “Mount” was scored when the male placed its forelimbs on the female’s back, climbed on top, and moved its pelvis. Rhythmic pelvic movements following a mount were scored as “Intromission”. “Ejaculation” was scored when the male displayed a deep thrust followed by firmly seizing the female in a stereotyped, immobile posture after intromission, as shown in Extended Data Video 1-4. The onset of mount is defined as the first frame when the male grasped and mounted the female’s flanks by his forelimbs; the onset of intromission is defined as the first frame when the male began rapid and rhythmic pelvic thrust; the onset of ejaculation is defined as the first frame of the last deep thrust.
Single-nucleus RNA sequencing
Sample preparation, library generation, and sequencing
For sample preparation for the Act-Seq (Fig. 1), males were tested in parallel in the same room, following a similar handling procedure. A hormone-primed female mouse was introduced into the males’ home cages. The behavioral test was terminated once one of the tested males achieved ejaculation or more than five intromissions. The animals that ejaculated were assigned to the "ejaculation" group, while those achieved intromission but not ejaculation were assigned to the "intromission" group. All animals were sacrificed approximately 30 minutes after the behavioral test ended.
Mice were anesthetized with isoflurane, perfused trans-cardinally with ice-cold oxygenated (95% O2/5% CO2) cutting solution (in mM: 2.5 KCl,1.25 NaH2PO4, 2 Na2HPO4, 2 MgSO4, 213 sucrose, 26 NaHCO3). The brain was promptly placed in ice-cold oxygenated cutting solution and sectioned at 250 μm using a vibratome (VT1200S, Leica). Immediately after the sectioning, brain slices were transferred to the dissection chamber with ice-cold oxygenated ACSF (in mM: 126 NaCl, 2.5 KCl, 1.25 NaH2PO4, 1.25 Na2HPO4, 2 MgSO4, 10 glucose, 26NaHCO3, 2 CaCl2) containing Actinomycin D (1 μM, CST, 15021S). Then, the preoptic area (POA) was carefully dissected according to the Allen brain atlas (www.brain-map.org) and collected to the corresponding tubes that were stored on the dry-ice. After the collection of POA from all qualified mice for either group, tubes were put into the liquid nitrogen before being processed further for library construction and sequencing. The durations of the dissection procedure for each animal were less than 10 min from the time point of perfusion to frozen in the tube. Three mice were included in either group. Subsequent steps, including the preparation of single-nucleus suspensions, library construction, and sequencing, were carried out by BGI Genomics using the Chromium Next GEM Single Cell 3’ Kit V3.1 (10X Genomics) in accordance with the manufacturer's protocol.
Normalization, clustering, and differential gene expression
Raw sequencing files were aligned to the mm10 mouse genome (GRCm38) and converted to gene expression matrices using the Cell Ranger pipeline (Cell Ranger 7.2.0) with default parameters. Intronic reads were included to enhance assay sensitivity.
All downstream analyses of scRNA-seq data were performed using the R package Seurat (v4). First, the scRNA-seq datasets were merged to generate the integrated file, and the quality of the sequenced cells was assessed. Outlier cells were identified based on the following criteria: 1) fewer than 200 detected genes (indicating potential fragment or dead cells); 2) the UMI count of mitochondrial genes exceeding 5% (indicating potential dead cells); 3) more than 6,000 genes (indicative of multiplets), and were filtered out. To focus on neurons, coarse preliminary clustering was performed to define major cell types. Clusters that lack expression of neuronal genes including Snap25, Stmn2, Gad1/Gad2/Slc17a6 or those that express conventional non-neuronal cell markers including Gfap, Pdgfra, Aqp4, C1qc, Gja1, Cldn5, Opalin, Mustn1 were excluded from further analysis. The final dataset comprised 27,447 neuronal nuclei, with 15,453 from the intromission group and 11,768 from the ejaculation group.
The expression of each gene in each cell was normalized by total number of UMI counts detected in that cell, then multiplied by a scale factor of 10,000 prior to log transformation (NormalizeData function). Gene expression values were then scaled by mean/variance across cells to range between 0 and 1, and the proportion of mitochondrial UMIs were regressed out (ScaleData function). Clustering using FindClusters function yielded unique transcriptomic clusters. The analysis and clustering procedures were as follows: Firstly, highly variable genes were identified (FindVariableGenes function; top 3,000 genes with the highest standardized variance selected by selection.method =‘vst’) and used as input for dimensionality reduction via principal component analysis (PCA) after removing immediate early genes (e.g., Fos, Fosl2, Junb, Egr1, Arc, Homer1; 139 genes in total as previously described25). Secondly, the PCs from previous step were used for clustering analysis (FindClusters function). Thirdly, differentially expressed genes in subclusters were detected using the FindAllmarkers function.
To identify neurons activated under ejaculation or intromission conditions, neurons with the IEGs’ count greater than 0 were classified as IEGs+, while all other neurons were classified as IEGs–. To identify activated neuronal clusters, the enrichment score of IEG+ neurons relative to IEG- neurons for each immediate early genes (IEGs) within each neuronal clusters was calculated using a binomial test for the ejaculation or intromission conditions separately, with false discovery rate (FDR) correction, and plotted in Fig. 1d and Extended Data Fig. 2.
Fiber photometry recording
Fiber photometry recordings were conducted as previously described8. Briefly, the virus was allowed to express for 3 to 4 weeks before recording. Males were singly housed for 3 to 7 days before fiber photometry recording and were trained by co-housing with hormone-primed females overnight twice to gain sexual experience. Before each recording session, the implanted optic fiber was connected to the recording setup (Biolink Optics Technology Inc., Beijing) via an external patch cord. A 488 nm excitation laser (OBIS 488LS; Coherent) was reflected off a dichroic mirror (MD498, Thorlabs) and directed to the neural tissues through the implanted optic fibers. After the patch cord was attached to the optic fiber implanted in the mice, they were allowed to move freely and acclimate to the device for 5 minutes.
During signal recording, males were first recorded for 3 minutes to collect fluorescent baseline signals. The detected fluorescence was filtered with a band pass filter (MF525-39, Thorlabs) and collected by a photomultiplier tube (PMT, R3896, Hamamatsu). Emission signals were low-pass filtered at 30 Hz and sampled at 500 Hz using a data acquisition card (USB6009, National Instrument) with software provided by Biolink Optics. Subsequently, a hormonally primed female was introduced into the male’s cage, and fluorescent signals were recorded until the male achieved ejaculation or 60 minutes had elapsed since the female’s introduction.
To analyze signals from fiber photometry experiments, raw fluorescence signals were adjusted for overall trends to account for photobleaching. Animals showing jitter, square wave signals, or low signal-to-noise ratios were excluded from further analysis. Behavior annotations were consistent with those used in the mating test. To align fluorescence signals with behaviors, data were segmented based on behavioral events within individual trials, and average signals of 10 to 15 seconds before behavior initiation were used as F0. Fluorescence changes (ΔF/F) were calculated as (F−F0)/F0 and averaged first across trials and then across animals. For statistic comparison, the average (ΔF/F) signals during behavior were compared to 0 using a one-sample t-test to determine statistical significance.
Optogenetic Inhibition
A bilateral bundled optic fiber (Inper, Co., Ltd) was used to connect a 589 nm laser power source (Changchun New Industries Optoelectronics Tech Co., Ltd.) to the implanted optic fiber in the animal. The external optical fiber was attached to a rotary joint (Doric Lense) to allow the animal to move freely with attached fibers. The tested animal was allowed to first explore the cage for about 10 to 15 min with the external fiber attached. After that, a hormonally primed female was introduced. Then, a custom-written program in MATLAB was started to control a Master 9 (A.M.P.I.), which sent a trigger signal to initiate recordings from the camera. Yellow light (~ 6 mW) was automatically triggered and continuously delivered whenever the tested animal was detected within one body length (~ 9 cm) of the female during the 30-minute mating behavior tests. Light inhibition trials and no-light trials were alternated randomly for each animal.
Optogenetic Activation
An optic fiber (Inper, Co., Ltd) was used to connect a 473 nm laser power source (Shanghai Laser and Optics Century Co.) to the implanted optic fiber in the animal. The external optical fiber was attached to a rotary joint (Doric Lense) to allow the animal to move freely with the fibers attached. The animal was first allowed to explore the cage for about 10 to 15 minutes with the external fiber attached. Afterward, a hormonally primed female was introduced. A custom-written MATLAB program was then initiated to control a Master 9 (A.M.P.I.), which sent a trigger signal to start camera recordings and controlled the laser to deliver eight 15 seconds of photo-stimulation at 20Hz, 12 mW, spaced randomly 90–120 seconds apart (POA activation), or a single 60-second photo-stimulation at 20Hz, 12 mW (ARC activation).
Conditioned Place Preference (CPP)
The CPP apparatus is an acrylic box consisting of three compartments, including a neutral middle zone (75 x 190 x 145 mm) and two distinct conditioning chambers (190 x 190 x 145 mm), with one featuring a mesh wire floor and white walls, and the other a slatted wire floor and black walls, providing distinct visual and tactile cues. The CPP apparatus was placed in a video-recording box illuminated by dim white light. Males interacted with a hormonally primed female in their home cage, within a similar video-recording box without light, before being placed into the CPP apparatus for conditioning.
The CPP procedure consisted of three phases over 4 days: pre-test, conditioning, and test. On day 1, during the pre-test, mice were introduced into the middle chamber and allowed to explore all three chambers freely for 15 minutes. The time spent in each chamber was recorded to identify the non-preferred and preferred chambers. On days 2 and 3, during the conditioning phase, mice underwent mating behavior testing and were immediately confined to one of the conditioning chambers for 30 minutes in a counterbalanced manner. On day 4, during the test phase, mice were placed in the middle zone and allowed to freely explore all chambers for 15 minutes. The time spent in each paired chamber was manually recorded and used to calculate a preference ratio, determined by dividing the time spent in the paired chamber by the total time spent in both conditioning chambers.
For ejaculation conditioning, mice reached ejaculation on one of the conditioning days and were confined to the initially less preferred chamber. On the other day, when they did not reach ejaculation, they were confined to the preferred chamber. For conditioning with optogenetic stimulation of Pomc+ neurons, animals, connected with an optic fiber, and a single trial of blue laser (10 mW, 20 Hz, 10 ms, 60 s) was delivered. On this day, mice were confined to the initially less preferred chamber, while the other day when no light was delivered the mice were confined to the preferred chamber.
For the pharmacological inhibition test, the CPP procedures were the same as the ejaculation-conditioning protocol, with the addition of saline or drug injections before the mating test on the conditioning day. Drugs, including SHU9119 (Tocris, Cat#3420), CTAP (Tocris, Cat#1560), or a mixture of the two, were administered prior to ejaculation pairing. Briefly, a dummy injector was inserted into the guide cannula to ensure a clear passage, and then removed. Drugs were microinjected into the lateral ventricle using a single injector (#62204, RWD Life Science) for intracerebroventricular (i.c.v.) injection. The injector extended 1 mm beyond the tip of the guide cannula and was connected by PE tubing to a 1 or 2 μL microinjection syringe mounted on a pump (Harvard Apparatus). Drugs included SHU9119 (0.5 nmol), CTAP (0.3 nmol), a mixture of both in 2 μL volume, or 2 μL of saline as a control. They were all injected at a rate of 30 nL/s. After injection, the injector was left in place for 30 seconds to allow drug diffusion before removal. The dummy injector and cap were then replaced, and the mice were returned to their home cages to undergo the mating test and conditioning.
CSF collection and endorphin measurement
Cerebrospinal fluid (CSF) was collected from mice following the protocol described previously57. A sharpened glass capillary with a tip diameter of approximately 10-20 µm was used for CSF collection. The capillary was connected to a syringe via a thin tube and a three-way valve, which allowed positive pressure to be applied to expel any contaminants. Mice, including those in the post-ejaculation, post-intromission, and opto-activation groups, were immediately anesthetized with 4% chloral hydrate. Afterward, the hair was removed from the back of the mouse’s head and the mouse’s head was positioned at a 45° angle, an incision was made to expose the base of the skull. The dura mater over the cisterna magna was then cleaned and dried, allowing approximately 10 uL of CSF to be collected using the prepared capillary. For some mice, after CSF collection, the wound was sutured, and the animals were allowed to recover for a week before a second collection. Each animal underwent no more than two CSF collections. CSF samples were stored at 4°C and processed with the ELISA test within a week or were stored at -20°C until testing. Endorphin levels were measured using the Mouse Beta-Endorphin, B-EP ELISA Kit (CUSABIO, Cat# CSB-E06827m), following the manufacturer’s protocols. Relative endorphin levels were normalized to the mean endorphin level of animals in either the intromission or the Pomc-Cre-EYFP group within each batch.
Immunohistochemistry
Animals were anesthetized with 0.2 mL 10% chloral hydrate in sterile saline and perfused with 15 mL PBS, followed by 15 mL ice-cold 4% PFA. Brains were dissected and post-fixed overnight in 4% PFA at 4℃. Brains were sectioned at 40 μm using a vibratome (VT1000S, Leica). Sections were washed with PBS and blocked with blocking reagent (5% goat serum, 0.1% Triton X-100, 2 mM MgCl2 in PBS) for 1 hour at room temperature. Then sections were incubated in AGT solutions (0.5% goat serum, 0.1% Triton X-100, 2 mM MgCl2 in PBS) with appropriate primary antibody overnight at 4℃. On the second day, slices were washed with AGT solutions three times and incubated in AGT solutions with appropriate secondary antibodies for 2 hours at room temperature. Slices were then rinsed in AGT solutions and counterstained with DAPI (dilution 1:1,000, Sigma, 5 mg / mL, Cat #d9542) for 10 min. Then, slices were washed in PBS solutions and mounted to slides. For GCaMP6s and EYFP staining, the primary antibody was anti-GFP antibody (dilution 1:1,000, ABCAM, Cat #ab13970), and the second antibody was goat-anti-chicken conjugated with Alexa fluor 488 (Jackson ImmunoResearch, Cat# 103-545-155, 1:1,000). For mCherry staining, the primary antibody was anti-dsRed antibody (dilution 1:1000, Clontech, Cat #632496), and the second antibody was goat anti-rabbit conjugated with Cy3 (Jackson ImmunoResearch, Cat# 111-165-003, 1:1,000). For Calb1 staining, the primary antibody was anti-Calbindin1 antibody (dilution 1:1,000, swant, Cat #CB-38a), and the second antibody was goat anti-rabbit conjugated with Cy3 (Jackson ImmunoResearch, Cat# 111-165-003, 1:1,000). For ACTH staining, the primary antibody was anti-ACTH/CLIP (dilution 1:100, santa cruz, Cat #373878), and the second antibody was goat anti- mouse conjugated with 647 (Jackson ImmunoResearch, Cat# 115-605-003). For c-Fos staining, the primary antibody was anti-c-Fos (dilution 1:1000, synaptic system, Cat #226308, 1:1,000), and the second antibody was goat anti- Guinea pig conjugated with Cy3 (Jackson ImmunoResearch, Cat# 111-165-003, 1:1,000). Images were captured by a 10 X objective on a fluorescent microscope (Olympus, VS120) or a confocal microscope (Nikon, C2). Images were processed and counted using the NIH ImageJ software. All analyses were done by an experimenter blind to the genotype and the drug treatment information.
In situ hybridization
DNA templates for generating in situ Calb1 probes were cloned using the following primer sets: Forward 5’- gaactattcaggatgtgtggca -3’ and Reverse 5’-gggctatggtcatactctctgg-3’. Anti-sense RNA probes were transcribed with T7 RNA polymerase (Promega, Cat# P207E) and digoxigenin (DIG)-labeled nucleotides. Animals were anesthetized with 10% chloral hydrate and transcardially perfused with DEPC-treated PBS (DEPC-PBS) followed by ice-cold 4% paraformaldehyde (PFA). Afterward, brains were sectioned at 40 μm thickness using a vibratome (VT1000S, Leica). Brain sections were washed in 2XSSC buffer containing 0.1% triton for 30 min, acetylated in 0.1 M triethanolamine (pH 8.0) with 0.25% acetic anhydride (vol/vol) for 10 min, equilibrated in pre-hybridization solution for 2 h at 65 ℃ and subsequently incubated with 0.5 μg/ mL of Calb1 probes in hybridization buffer overnight at 65 ℃. The next day, sections were rinsed in pre-hybridization solution and pre-hyb/TBST (TBS with 0.1% tween-20) for 30 min each. Next, sections were washed with TBST for twice and TAE for three times, each for 5 min. Sections were then transferred into wells in 2% agarose gel, which were run in 1XTAE at 60 V for 2 h to remove unhybridized probes. Sections were then washed twice in TBST, and subsequently incubated with sheep anti-digoxygenin-AP (1:2000, Roche, Cat# 11093274910) in 0.5% blocking reagent (Roche, 11096176001) at 4 °C overnight. On the second day, sections were washed and stained with NBT (Roche, Cat# 11383213001) and BCIP (Roche, Cat# 11383221001) for 3 h at 37 ℃. All sections were washed after staining and mounted on glass slides. Images were captured with ×10 objective using a conventional microscope.
RNAscope
Animals were anesthetized with 0.2 mL of 10% chloral hydrate in sterile saline and perfused with 15 mL of DEPC-PBS, followed by 15 mL of ice-cold 4% PFA. Brains were dissected and post-fixed overnight in 4% PFA at 4 °C, then dehydrated in 30% sucrose in DEPC-PBS overnight. Subsequently, brains were sectioned at a thickness of 20 μm and mounted onto SuperFrost Plus® Slides (Fisher Scientific, Cat. No. 12-550-15). After air-drying, slides were stored at −80 °C until processing according to the RNAscope® Multiplex Fluorescent Reagent Kit v2 User Manual (ACD Bio.). Probes for Calb1 (Lot#428431-C2), Adcyap1 (Lot#409511-C1), Fos (Lot#316921-C3), and Pomc (Lot#314081-C1) were ordered from ACD Bio. and used in the experiment.
For RNAscope analysis combined with immunohistochemistry, after the completion of RNAscope procedures, brain slices were blocked for 1 hour at room temperature in PBS with 2.5% BSA, followed by incubation with the primary antibody chicken anti-GFP (1:300, Abcam, Ab13970) at 4 °C overnight. The secondary antibody goat anti-chicken IgG-Alexa 488 (1:300, Jackson ImmunoResearch Laboratories, 103-545-155) was applied in PBS with 1.25% BSA at room temperature for 2 hours. Brain sections were then rinsed three times with PBS and counterstained with DAPI (Sigma, Cat# d9542, 5mg/mL, dilution 1:1000). All images were captured using a 20× objective on a confocal microscope and processed and counted using NIH ImageJ software.
Quantification of axonal projection and RV inputs
To quantify the axonal projection, every other section of coronal serial sections of 40 μm thickness was imaged using a conventional microscope with a 10x objective lens (0.6499 mm / pixel, VS120, Olympus). To correct for the non-specific background noise of each brain section, the whole image of the brain sections were first evened using a custom written MATLAB (MathWorks) code that extract pixels with value between 2 standard deviation of the mean intensity. The average pixel intensity in a target brain region containing ChR2-mCherry terminals signals was then corrected by subtracting the background intensity value obtained from an adjacent brain region that did not contain mCherry+ signals. This corrected value was then normalized to the pixel intensity of the POA containing the ChR2-mCherry+ neuronal soma for each animal.
To quantify the number of retrogradely labeled RV-dsRed neurons, every other coronal section (40 μm thickness) was imaged using a conventional microscope (10x objective lens, 0.6499 mm/pixel, VS120, Olympus). Labeled cells in each region of interest were manually counted by experimenters. Brain areas were identified using DAPI immunostaining and the mouse brain atlas (Paxinos and Franklin's The Mouse Brain in Stereotaxic Coordinates). The number of RV labeled neurons in upstream brain regions were normalized to the number of starter neurons (GFP+/dsRed+ neurons in the ARC) for each animal. All analyses were conducted on raw images without any post-acquisition modifications.
Electrophysiological recordings in brain slices
Calb1-Cre mice injected with AAVs encoding Cre-dependent NpHR3.0-mCherry in the POA were anesthetized with isoflurane and transcardially perfused with ice-cold oxygenated (95% O2/5% CO2) high-sucrose solution (composition in mM: 2.5 KCl, 1.25 NaH2PO4, 2 Na2HPO4, 2 MgSO4, 213 sucrose, 26 NaHCO3). After brain dissection, coronal sections including the POA were cut at 250 μm using a vibratome (VT-1200S, Leica) in ice-cold oxygenated cutting solution. Brain slices were then incubated in artificial cerebrospinal fluid (ACSF; composition in mM: 126 NaCl, 2.5 KCl, 1.25 NaH2PO4, 1.25 Na2HPO4, 2 MgSO4, 10 glucose, 26 NaHCO3, 2 CaCl2) at 34 °C for at least 1 hour. Cells were identified under a fluorescent microscope and visualized by infrared differential interference contrast (BX51, Olympus). Whole-cell recordings were conducted using a MultiClamp700B amplifier and Digidata 1440A interface (Molecular Devices). Recording electrodes (3–5 MΩ, Borosilicate Glass, Sutter Instrument) were prepared with a micropipette puller (Sutter Instrument, model P97). The patch-clamp electrode was backfilled with an intracellular solution (composition in mM: 120 K‐gluconate, 4 KCl, 10 HEPES, 10 sodium phosphocreatine, 4 Mg‐ATP, and 0.3 Na3‐GTP, pH 7.3, 265 mOsm). For optogenetic inhibition, stable action potentials were induced in NpHR-expressing neurons via current injection under current clamp, followed by repeated application of continuous yellow light onto the slices. Data were recorded using Clampex 10.2 (Molecular Devices) and low-pass filtered at 10 kHz and sampled at 10 kHz under current clamp. All experiments were performed at 33 °C using a temperature controller (Warner, TC324B).
Statistics
Statistical analyses were performed using Prism 10 (GraphPad Software). For bar graphs, values are presented as mean ± SEM. To compare the two groups, we first tested the data with the Lilliefors’ goodness of normality test; then variances were tested with F-test; if the data were fitted into normal distribution and equal variances, p values were calculated with paired or unpaired Student’s t-test. For unpaired data and not fitting a normal distribution, a non-parametric Mann–Whitney U-test was used. For data without equal variances, the paired or unpaired t test with Welch's correction was used. For comparisons among data from paired three groups in Figure2h and Extended Figure5, repeated measures ANOVA followed by Šídák's multiple comparisons test was used. For comparisons among data with the hypothesized value of the mean in Figure4, one sample test was used. Chi-square test with the p value adjusted for false discovery rate (FDR) of 1% using two-stage step-up method of Benjamini, Krieger and Yekutieli was used to analyze categorical data in Figure1e. FDR adjustment was also used in Extended Figure7 for correction of p-values after multiplied comparisons. For comparisons of survival distributions between two groups, Log-rank (Mantel-Cox) test was used. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. For more detailed information, refer to Extended Data Table 1.